SEC Form D private-offering filing

Pacegenix, Inc.

Name: Pacegenix, Inc. - new SEC Form D private-offering filing, Cambridge, MA
Published: 2026-03-26

A new SEC Form D private-offering notice from Cambridge, MA, a $22,533,267 filer-stated offering target in Biotech. The source filing is one click away.

Pacegenix, Inc. site↗ Verified via SEC Form D

Develops precision cardiology therapeutics for heart rhythm disorders, including treatments for atrial fibrillation in hypertrophic cardiomyopathy and inappropriate rapid heart rate conditions

Filed 2026-03-26Filed to raise $22,533,267First money in 2026-03-11Raised so far $22,533,267HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified pacegenix.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.